Open AccessSpectral-Domain Optical Coherence Tomography-Driven Treat-and-Extend and Pro Re Nata Regimen in Patients with Macular Oedema due to Retinal Vein Occlusion: 24-Month Evaluation and Outcome Predictors
Author(s) -
Maria-Magdalena Guichard,
Anton R Xavier,
Cengiz Türksever,
Christian Pruente,
Katja Hatz
Publication year - 2018
Publication title -
ophthalmic research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.893
H-Index - 54
eISSN - 1423-0259
pISSN - 0030-3747
DOI - 10.1159/000487489
Subject(s) - pro re nata , medicine , ophthalmology , retinal , ranibizumab , visual acuity , branch retinal vein occlusion , macular edema , nuclear medicine , bevacizumab , chemotherapy
To analyse the efficacy and outcome predictors of ranibizumab using a spectral-domain optical coherence tomography (SD-OCT)-driven treat-and-extend regimen (TER) versus SD-OCT-driven pro re nata regimen (PRN) in patients with cystoid macular oedema (CME) due to branch or central retinal vein occlusion (BRVO, CRVO).